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The Journal of Immunology
Unconventional Human T Cells Accumulate at the Site of
Infection in Response to Microbial Ligands and Induce Local
Tissue Remodeling
Anna Rita Liuzzi,* Ann Kift-Morgan,* Melisa Lopez-Anton,*,† Ida M. Friberg,*,1
Jingjing Zhang,* Amy C. Brook,* Gareth W. Roberts,†,‡ Kieron L. Donovan,†,‡
Chantal S. Colmont,† Mark A. Toleman,* Timothy Bowen,*,† David W. Johnson,x,{,‖
Nicholas Topley,#,** Bernhard Moser,*,** Donald J. Fraser,*,†,‡,** and Matthias Eberl*,**
The antimicrobial responsiveness and function of unconventional human T cells are poorly understood, with only limited access to
relevant specimens from sites of infection. Peritonitis is a common and serious complication in individuals with end-stage kidney
disease receiving peritoneal dialysis. By analyzing local and systemic immune responses in peritoneal dialysis patients presenting
with acute bacterial peritonitis and monitoring individuals before and during defined infectious episodes, our data show that Vg9/
Vd2+ gd T cells and mucosal-associated invariant T cells accumulate at the site of infection with organisms producing (E)-4-
hydroxy-3-methyl-but-2-enyl pyrophosphate and vitamin B2, respectively. Such unconventional human T cells are major pro-
ducers of IFN-g and TNF-a in response to these ligands that are shared by many microbial pathogens and affect the cells lining
the peritoneal cavity by triggering local inflammation and inducing tissue remodeling with consequences for peritoneal membrane
integrity. Our data uncover a crucial role for Vg9/Vd2 T cells and mucosal-associated invariant T cells in bacterial infection and
suggest that they represent a useful predictive marker for important clinical outcomes, which may inform future stratification and
patient management. These findings are likely to be applicable to other acute infections where local activation of unconventional
T cells contributes to the antimicrobial inflammatory response. The Journal of Immunology, 2016, 197: 2195–2207.
T
he classical view of the immune response to infection is
based on the assumption that “innate” immune cells sense
pathogens via pattern recognition receptors such as the
TLRs, whereas Ag-specific “adaptive” T cell responses are restricted
by molecules of the MHC. This simplistic model is being eroded by
the growing realization that substantial numbers of T cells in the
body are non-MHC restricted and integrate innate and adaptive
features (1, 2). Such innate-like T cells include gd T cells, mucosal-
associated invariant T (MAIT) cells, NKT cells, germline-encoded
mycolyl-reactive T cells and other CD1-restricted T cells (3–8). To-
gether, these “unconventional” T cell populations make up a size-
able proportion of all T cells in blood, epithelia, organs such as the
liver, and inflamed tissues. Sensing nonpeptide Ags by unconven-
tional T cells endows the body with the capacity to respond to a
plethora of foreign and self-molecules produced by invading path-
ogens or released by stressed, infected, or metabolically active tis-
sues. In humans, microbial organisms sensed by one or more of
these T cell subsets include the causative agents of tuberculosis,
malaria, and most hospital-acquired bacterial infections (9).
There is an increasing appreciation of the role played by uncon-
ventional T cells in orchestrating early cellular events in response to
invading pathogens, which is likely to contribute to microbial
clearance and the development of immunological memory, but
which may also result in inflammation-associated tissue damage
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(1, 9–11). Progress in the understanding of unconventional T cell
biology has been hampered by their responsiveness to relatively
poorly defined structures and the paucity of appropriate experimental
research tools. These cells also display striking species-specific
differences with respect to their TCR repertoires, activities, and
anatomical locations, with the restricting elements butyrophilin-3
(BTN3), CD1a, CD1b, and CD1c as well as the corresponding
T cell subpopulations being absent in mice (1, 8, 9, 12). As a con-
sequence, no small animal model replicates the complex interactions
between unconventional T cells and other immune and nonimmune
cells in the human body.
The characterization of unconventional T cell responses in vivo
and their relevance for homeostasis, immune surveillance, and in-
flammation remains challenging (3–9). In particular, the microbial
and environmental signals that lead to the migration, differentia-
tion, expansion, and maintenance of unconventional T cells under
physiological conditions are poorly defined. Studies into human
responses during acute infections are notoriously difficult to under-
take, with only limited access to relevant specimens, in particular
from the site of infection, and to matched samples collected before
disease onset. In this study, we addressed this knowledge gap by
studying a well-defined cohort of individuals receiving peritoneal
dialysis (PD) and presenting with acute peritonitis. PD is a live-
saving treatment for people with end-stage kidney disease that
permits immunological investigations with direct clinical relevance,
where a permanently inserted catheter affords continuous and non-
invasive access to localized responses to a range of bacterial species
(13–15). We recently reported elevated numbers of Vg9/Vd2 T cells
in a cross-sectional cohort of PD patients with acute peritonitis,
particularly in those with infections caused by Gram-negative and
(E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP)–
producing bacteria (14, 15). However, it is unclear whether those
elevated numbers are due to preferential recruitment of uncon-
ventional T cells to the peritoneal cavity in certain infections and/
or a result of ligand-specific local activation and expansion in re-
sponse to the respective pathogens.
Our present data show that both Vg9/Vd2 T cells and MAIT cells
specifically accumulate at the site of infection in response to or-
ganisms producing HMB-PP and vitamin B2, respectively, and have
the capacity to activate local tissues with consequences for acute
inflammation, peritoneal membrane integrity, and clinical outcomes.
In a wider context, the current study demonstrates the power of
using PD as an experimental and clinical model for monitoring in-
dividuals before, during, and after defined microbial infections.
Materials and Methods
Study approval
Recruitment of PD patients and healthy volunteers for this study was ap-
proved by the South East Wales Local Ethics Committee under reference
numbers 04WSE04/27 and 08/WSE04/17, respectively, and conducted
according to the principles expressed in the Declaration of Helsinki. All
individuals provided written informed consent. The PD study was registered
on the U.K. Clinical Research Network Study Portfolio under reference
numbers 11838 “Patient immune responses to infection in Peritoneal Di-
alysis” (PERIT-PD) and 11839 “Leukocyte phenotype and function in
Peritoneal Dialysis” (LEUK-PD). Fresh omentum samples from consented
patients were obtained from the Wales Kidney Research Tissue Bank.
Patient samples
The local study cohort comprised 101 adults PD patients admitted to the
University Hospital of Wales, Cardiff, on day 1 of acute peritonitis between
September 2008 and April 2016. Forty-one stable individuals receiving PD
for at least 3 mo and with no previous infection served as noninfected
controls. Subjects known to be positive for HIV or hepatitis C virus were
excluded. Clinical diagnosis of acute peritonitis was based on the presence
of abdominal pain and cloudy peritoneal effluent with .100 WBCs/mm3.
According to the microbiological analysis of the effluent by the routine
Microbiology Laboratory, Public Health Wales, episodes of peritonitis
were defined as culture negative (with unclear etiology) or as confirmed
bacterial infections caused by specific subgroups of Gram-positive and
Gram-negative organisms. The distribution of the nonmevalonate (HMB-
PP) and vitamin B2 pathways across microbial species was determined
based on the absence or presence of the enzymes HMB-PP synthase (EC
1.17.7.1) and 6,7-dimethyl-8-D-ribityllumazine (DMRL) synthase (EC
2.5.1.78), respectively, in the corresponding genomes, according to the
Kyoto Encyclopedia of Genes and Genomes (KEGG; http://www.genome.
jp/kegg). Cases of fungal infection and mixed or unclear culture results
were excluded from this analysis.
Outcome analysis
Microbiological and clinical outcome data were obtained from 5071 adult
patients of the Australia and New Zealand Dialysis Transplant (ANZDATA)
Registry who developed first-time peritonitis between April 2003 and
December 2012, excluding cases of fungal infection, polymicrobial infec-
tion, or unrecorded culture results. Clinical outcomes examined were
cessation of therapy because of catheter removal in 90 d, transfer to per-
manent hemodialysis (HD) in 90 d, transfer to interim HD for at least 30 d
and death in 30 d, as well as the individuals outcomes combined to yield the
overall technique failure. Outcome predictors were determined using binary
logistic regression and forward elimination of data. Survival analyses were
performed using the Kaplan–Meier approach, and differences between
groups were assessed using log-rank tests.
Media, reagent, and Abs
Peritoneal leukocytes were cultured in RPMI 1640 medium supplemented
with 2 mM L-glutamine, 1% sodium pyruvate, 50 mg/ml penicillin/
streptomycin, and 10% FCS (Life Technologies). Mesothelial cells were
cultured in Earle’s buffered Medium 199 (Life Technologies) containing
10% FCS, and peritoneal fibroblasts were cultured in a 1:1 (v/v) mixture of
DMEM and Ham’s F-12 nutrients (Life Technologies) with 20% FCS; both
media were supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin,
and 2 mM L-glutamine (Life Technologies) as well as 5 mg/ml transferrin,
5 mg/ml insulin, and 0.4 mg/ml hydrocortisone (all from Sigma-Aldrich).
Synthetic (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP)
was provided by Dr. H. Jomaa (University of Giessen, Giessen, Germany)
and synthetic DMRL by Dr. B. Illarionov (Hamburg School of Food Science,
Hamburg, Germany). Biotinylated monomers of human MHC-related
protein 1 (MR1) loaded with reduced 6-hydroxymethyl-8-(1-D-ribityl)
lumazine (active ligand) or 6-formylpterin (negative control) were pro-
vided by Dr. L. Kjer-Nielsen (University of Melbourne, Melbourne, VIC,
Australia) and reconstituted as described before (16). rIFN-g, rTNF-a, and
rIL-1b were purchased from Miltenyi Biotec. Human T-Activator CD3/
CD28 Dynabeads were purchased from Life Technologies. Blocking re-
agents used included anti-BTN3 (103.2; Dr. D. Olive, Universite´ de la
Me´diterrane´e, Marseille, France); anti-MR1 (26.5; Dr. T. Hansen, Wash-
ington University School of Medicine, St. Louis, MO); anti–IFN-g (B27)
and anti–IL-1b (H1b-27) (BioLegend); and sTNFR p75-IgG1 fusion pro-
tein (etanercept/Enbrel; Amgen).
Bacteria
Clinical isolates of Escherichia coli (Gram2HMB-PP+vit.B2+), Klebsiella
pneumoniae (Gram2HMB-PP+vit.B2+), Pseudomonas aeruginosa
(Gram2HMB-PP+vit.B2+), Corynebacterium striatum (Gram+HMB-PP+vit.B2+),
Listeria monocytogenes (Gram+HMB-PP+vit.B22), Staphylococcus aureus
(Gram+HMB-PP2vit.B2+), Streptococcus pneumoniae (Gram+HMB-PP2vit.B22),
and Enterococcus faecalis (Gram+HMB-PP2vit.B22) were grown in
Luria–Bertani broth, harvested at an OD600 of 0.5–0.8, and sonicated in
1/10 (v/v) PBS (pH 8). Insoluble debris was removed by centrifugation,
the supernatants were passed through 0.1-mm sterile filter units (Millipore),
and the protein concentrations were determined using the BCA protein
assay kit (Pierce). Low molecular mass fractions were obtained using
cellulose filters with a molecular mass cutoff of 3 kDa (Millipore).
Bacterial extracts were used in cell culture at dilutions corresponding
to protein concentrations of the original samples (before 3-kDa filtration) of
60–100 mg/ml.
T cells
PBMC were isolated from peripheral blood of healthy volunteers using
Lymphoprep (Axis-Shield). Vg9+ T cells (.98%) were isolated from
PBMC using mAbs against Vg9-PECy5 (Beckman Coulter) and anti-PE
magnetic microbeads (Miltenyi Biotec); Va7.2+ T cells (.98%) were isolated
using anti–Va7.2-allophycocyanin (BioLegend) and anti-allophycocyanin
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microbeads (Miltenyi Biotec). To generate unconventional T cell–conditioned
medium, purified blood Vg9/Vd2 T cells and MAIT cells were incubated for
24 h in the presence of 10 nM HMB-PP and anti-CD3/CD28 Dynabeads at
0.5 beads/cell, respectively. Human peritoneal leukocytes were harvested from
overnight dwell effluents of stable PD patients (13) and cultured in the ab-
sence or presence of 1–100 nM HMB-PP, 100 mM DMRL, or bacterial ex-
tracts at dilutions corresponding to protein concentrations of 60–100 mg/ml.
For blocking experiments, anti-BTN3 and anti-MR1 were used at 10 mg/ml
and added 30 min before stimulating the cells.
Mesothelial cells and peritoneal fibroblasts
Human peritoneal mesothelial cells were obtained from fresh omental
samples after two cycles of tissue digestion in the presence of trypsin
(15 min each); peritoneal fibroblasts were obtained after a third digestion
cycle lasting 1 h (17–19). All data presented are from experiments per-
formed with confluent mesothelial cells and fibroblasts between the first
and third passage. Mesothelial cells were growth arrested for 48 h in
serum-free medium prior to treatment; fibroblasts were growth arrested in
medium containing 0.2% FCS. After starvation, cells were exposed for
24 h to T cell–conditioned medium at the indicated dilutions; rTNF-a and
rIFN-g were used as controls. Cell-free peritoneal effluent from stable and
infected patients (n = 3–4) was added to cell cultures at a dilution of 1:4. In
blocking experiments, T cell–conditioned medium or peritoneal effluent were
pretreated for 30 min with anti–IFN-g, anti–IL-1b, and sTNFR, either alone
or in combination at 10 mg/ml. Supernatants were harvested and assessed by
ELISA; cells were analyzed by quantitative PCR.
Flow cytometry
Cells were acquired on an eight-color FACSCanto II (BD Biosciences) and
analyzed with FlowJo 10.1 (Tree Star), using mAbs against CD3 (SK7),
CD69 (FN50), CCR4 (1G1), CCR5 (2D7), and CCR6 (11A9) from BD
Biosciences; anti–TCR-Vg9 (Immu360) from Beckman Coulter; and anti-
CD161 (HP-3G10), CCR2 (K036C2), anti–TCR-Va7.2 (3C10) (Bio-
Legend), together with appropriate isotype controls. Anti-mouse beads
were used to set compensation (Life Technologies). Intracellular cytokines
were detected using anti–IFN-g (B27; BioLegend) and anti–TNF-a (188;
Beckman Coulter). For detection of intracellular cytokines, 10 mg/ml
brefeldin A (Sigma-Aldrich) was added to cultures 5 h prior to harvest-
ing. Leukocyte populations were gated based on their appearance in side
scatter and forward scatter area/height and exclusion of live/dead staining
(fixable Aqua; Invitrogen). Unless stated otherwise, peritoneal gd T cells
were defined as Vg9+CD3+ lymphocytes. Peritoneal MAIT cells were defined
as Va7.2+CD161+CD3+ lymphocytes; control stainings using MR1 tetramers
as reference confirmed the validity of this approach (data not shown).
ELISA
Cell-free peritoneal effluents were analyzed on a SECTOR Imager 6000 (Meso
Scale Discovery) for IFN-g, TNF-a, IL-1b, CCL3, CCL4, and CXCL8.
Conventional ELISA kits and a Dynex MRX II reader were used for CCL2
(eBioscience) and CCL20 (R&D Systems). Cell culture supernatants were
analyzed using conventional ELISA kits for IFN-g (BioLegend), TNF-a and
CCL2 (eBioscience) as well as for CXCL8, CXCL10, and IL-6 (R&D
Systems).
Real-time PCR
Total RNAwas isolated from mesothelial cells cultured under the indicated
conditions using TRIzol (Invitrogen). cDNAwas generated from 0.5 mg of
RNA using the high-capacity cDNA reverse transcription kit (Thermo
Fisher), 100 mM 29-deoxynucleoside 59-triphosphates, 40 U/ml RNase
inhibitor (New England Biolabs), 50 U/ml MultiScribe reverse transcrip-
tase, and 13 random primers, according to the manufacturer’s recom-
mendations. Quantitative PCRs were run on a ViiA7 real-time PCR system
(Thermo Fisher), using the power SYBR green PCR master mix (Thermo
Fisher) and 300 nM forward and reverse primers: 59-TCCCAATACATC-
TCCCTTCACA-39 and 59-ACCCACCTCTAAGGCCATCTTT-39 for E-
cadherin; 59-TAAATCCACGCCGGTTCCTGAAGT-39 and 59-AGGTGTCTC-
AAAGTTACCACCGCT-39 for occludin; 59-CCGAGGTTTTAACTGCGAGA-
FIGURE 1. Proinflammatory migratory profile of
unconventional T cells. (A) Total cell counts and con-
centration of the neutrophil-attracting chemokine
CXCL8 in the peritoneal effluent of stable PD patients
and patients presenting with acute peritonitis. (B) Total
numbers of Vg9+CD3+ T cells and Va7.2+CD3+ T cells
within the peritoneal cell population in stable PD pa-
tients and during acute peritonitis. (C) Representative
example for the coexpression of CCR2, CCR5, and
CCR6 with CD161 on blood Va7.2+CD3+ T cells in a
stable PD patient. (D) Percentage of CCR2+, CCR5+,
and CCR6+ cells among Vg92 and Vg9+CD3+
T cells (upper panels) or among Va7.2+CD1612 and
Va7.2+CD161+CD3+ T cells in the blood of stable PD
patients (lower panels). (E) Concentration of the indi-
cated chemokines in the effluent of patients presenting
with acute peritonitis; upper limits of detection for
CCL3 and CCL4 were 4.12 and for 4.32 ng/ml, re-
spectively. Data were analyzed using Mann–Whitney
tests (in the case of CCL2 after normalization). Each
data point represents an individual patient, error bars
depict the median 6 interquartile range.
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39 and 59-TCACCCACTCGGTAAGTGTTC-39 for fibronectin; 59-CGAGC-
CCACCGGGAACGAAA-39 and 59-GGACCGAAGGCGCTTGTGGAG-39 for
IL-6; 59-CCTCTGACTTCAACAGCGACAC-39 and 59-TGTCATACCAG-
GAAATGAGCTTGA-39 for GAPDH; 59-TTTACCTTCCAGCAGCCCTA-39
and 59-GGACAGAGTCCCAGATGAGC-39 for Snail; 59-AACTGGGACGA-
CATGGAAA-39 and 59-AGGGTGGGATGCTCTTCAG-39 for a-smooth
muscle actin; 59-GGAGAGGTGTTCCGTGTTGT-39 and 59-GGCTAGCTGCT-
CAGCTCTGT-39 for zona occludens-1; and 59-CGGGTTGCTTGCAATGTG-
C-39 and 59-CCGGCGACAACATCGTGAC-39 for claudin-1. Ten nanograms of
total RNA were used for cellular microRNAs (miRs) using the TaqMan
Universal Master Mix II and specific primers for miR-21 and miR-191
(Applied Biosystems). mRNA and miR expression levels were normalized
to the endogenous controls GAPDH and miR-191, respectively.
Statistics
Statistical analyses were performed using GraphPad Prism 6.0 software.
Data distributions were analyzed using D’Agostino–Pearson omnibus nor-
mality tests. Data were analyzed using two-tailed Student t tests for normally
distributed data and two-tailed Mann–Whitney tests for non-parametric data.
Differences between groups were analyzed using one-way ANOVA with
Holm–Sidak’s post tests for multiple comparisons of parametric data, or
Kruskal–Wallis tests combined with Dunn’s post tests for nonparametric
data. Matched data were analyzed using paired t tests or Wilcoxon matched-
pairs tests for two groups, or Friedman tests combined with Dunn’s multiple
comparisons tests for more than two groups. Differences were considered
statistically significant as indicated in the figures and tables: *p , 0.05,
**p , 0.01, and ***p , 0.001.
Results
Blood unconventional T cells migrate early into the inflamed
peritoneal cavity, at the time of peak neutrophil influx
Acute disease is characterized by a considerable influx of leuko-
cytes to the site of infection, together with locally elevated levels of
inflammatory mediators. In this study, the effluent of PD patients
presenting with acute peritonitis, before commencing antibiotic
treatment, contained increased levels of total cells and of chemokines
like the neutrophil-attracting molecule CXCL8 (IL-8), compared
with effluent from stable noninfected PD patients (Fig. 1A). Ab-
solute numbers of both Vg9/Vd2 T cells and MAIT cells were
increased during acute peritonitis compared with stable patients
(Fig. 1B), indicating rapid corecruitment of unconventional
T cells from blood to the inflamed peritoneal cavity, alongside
neutrophils. These observations were in agreement with the mi-
gratory profiles of these cells. Circulating Vg9/Vd2 T cells and
MAIT cells in stable PD patients preferentially expressed the che-
mokine receptors CCR2, CCR5, and CCR6, compared with their
non-Vg9 and non-MAIT counterparts (Fig. 1C, 1D). We detected
markedly increased levels of the corresponding chemokines CCL2
(CCR2 ligand), CCL3 and CCL4 (CCR5 ligands), and CCL20
(CCR6 ligand) in early peritonitis (Fig. 1E), demonstrating a sub-
stantial production of inflammatory chemokines with the potential
to attract unconventional T cells to the site of infection, thereby
complementing the local pool of tissue-resident Vg9/Vd2 T cells
and MAIT cells. In accordance, local frequencies of Vg9/Vd2
T cells and MAIT cells during peritonitis were generally higher
than in blood (Fig. 2A). No systemic increase in blood unconven-
tional T cell levels was seen in patients with peritonitis, in support
of the locally confined nature of the infection.
Unconventional T cells are locally enriched during acute
infections caused by bacterial pathogens producing the
corresponding ligands
To avoid confounding resulting from the considerable biological
variations between people and the underlying pathologies, we
collected matched samples from the same individuals to examine
systemic responses in blood and local responses in the peritoneal
cavity, before and during episodes of peritonitis. Such investiga-
tions in acutely infected people have not been attempted before and
are a unique advantage of studying individuals receiving PD. These
matched analyses in fact identified further ligand-specific effects on
local frequencies because Vg9/Vd2 T cells and MAIT cells were
particularly elevated in peritonitis caused by bacteria producing
HMB-PP and vitamin B2, respectively, even in individuals with
multiple infection episodes (Fig. 2B).
FIGURE 2. Systemic and local
levels of unconventional T cells in
stable PD patients and during acute
peritonitis. (A) Blood (PBMC) and
peritoneal dialysis effluent (PDE)
were analyzed by flow cytometry for
the proportion of Vg9/Vd2 T cells
(identified as Vg9+; left) and MAIT
cells (Va7.2+CD161+; right), expressed
as percentage of all CD3+ T cells.
Samples were collected from stable PD
patients and patients presenting with
acute peritonitis (day 1), before com-
mencing antibiotic treatment. Data
were analyzed using Kruskal–Wallis
tests combined with Dunn’s multiple
comparisons tests. Each data point
represents an individual patient; aster-
isks indicate significant differences
between groups. (B) Local levels of
unconventional T cells in the effluent
of two PD patients while the individu-
als were stable and when they presented
with distinct peritonitis episodes caused
by bacteria capable or not of producing
HMB-PP or vitamin B2 (day 1).
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Across the cohort, proportions of Vg9/Vd2 T cells among all
CD3+ T cells in blood and peritoneal cavity were comparable in
the absence of infection, indicating that under homeostatic con-
ditions Vg9/Vd2 T cells are not enriched locally (Fig. 3A). In
contrast, on the day of presentation with acute peritonitis, local
levels of Vg9/Vd2 T cells were elevated compared with blood,
suggesting preferential recruitment and/or accumulation at the site
of infection (Fig. 3B). This preferential increase in local Vg9/Vd2
T cell levels was apparent in patients infected with HMB-PP+
bacteria but not in patients with HMB-PP2 infections (Fig. 3B),
despite highly elevated peritoneal chemokine levels in both HMB-
PP+ and HMB-PP2 infections (data not shown). Finally, we per-
formed a longitudinal study and observed a significant increase in
local Vg9/Vd2 T cell levels in patients who developed acute
peritonitis caused by HMB-PP+ organisms over preinfection
baseline levels when the same individuals were stable (Fig. 3C).
Because there was no such difference between preinfection and
postinfection levels in individuals presenting with HMB-PP2 infec-
tions, these findings show that Vg9/Vd2 T cells accumulate locally at
the site of infection in response to HMB-PP+ but not HMB-PP2
organisms.
Parallel studies on the distribution of MAIT cells revealed
analogous patterns. Although in stable PD patients local MAIT cell
frequencies in the peritoneal cavity were slightly higher than those
in blood (Fig. 3D), such differences between anatomical sites were
much more pronounced in acutely infected individuals (average
4.65% of all T cells in the peritoneal cavity versus 0.91% in blood),
particularly during infections caused by vitamin B2–producing
(vit.B2+) bacteria (Fig. 3E). As observed for peritoneal Vg9/Vd2
T cell responses to HMB-PP+ bacteria, a comparison with matched
preinfection values revealed a significant local increase in MAIT
cell levels in individuals infected with vit.B2+ organisms (Fig. 3F),
confirming the responsiveness of MAIT cells to vitamin B2 deriv-
atives in vivo. These findings on Vg9/Vd2 T-cells and MAIT cells
support a ligand-induced local expansion of unconventional T-cells
at the site of infection, in addition to the ligand-independent re-
cruitment from the blood (Fig. 1B).
Peritoneal unconventional T cells respond to bacterial
pathogens producing the corresponding ligands
To address the pathogen specificity of local unconventional T cell
responses, we cultured peritoneal leukocytes from stable PD pa-
tients in the presence of different microbial stimuli. In agreement
with our earlier data on blood cells (10), peritoneal Vg9/Vd2
T cells were highly specific for HMB-PP, whereas MAIT cells rec-
ognized the vitamin B2 precursor, DMRL, as judged by upregulation
of CD69 and production of TNF-a by responding cells (Fig. 4A).
When testing extracts from defined clinical isolates covering the
majority of pathogens associated with PD-related peritonitis, peri-
toneal Vg9/Vd2 T cells responded readily to HMB-PP–producing
Gram-negative (E. coli, K. pneumoniae, and P. aeruginosa) and
Gram-positive bacteria (C. striatum and L. monocytogenes) but not
to HMB-PP–deficient E. faecalis and S. pneumoniae (Fig. 4B).
FIGURE 3. Matched levels of unconventional T cells
in blood and effluent of PD patients before and during
acute peritonitis. Blood and peritoneal effluent samples
from the same individuals were analyzed by flow
cytometry for the proportion of Vg9/Vd2 T cells
(identified as Vg9+) (A–C) and MAIT cells (Va7.2+
CD161+) (D–F), expressed as percentage of all CD3+
T cells. Samples were collected while patients were
stable and when they presented with acute peritonitis
(day 1), before commencing antibiotic treatment. (A
and D) Unconventional T cell levels in blood and ef-
fluent of stable individuals. (B and E) Unconventional T
cell levels in blood and effluent of all patients with
acute peritonitis (left) and in subgroups of patients with
confirmed infections by bacteria capable or not of
producing HMB-PP or vitamin B2 (middle, right). (C
and F) Local unconventional T cell levels in the effluent
of PD patients before and during acute peritonitis (left)
and in subgroups of patients with infections by bacteria
producing HMB-PP and/or vitamin B2 (middle, right).
Data were analyzed using Wilcoxon matched–pairs
signed rank tests. Each data point represents an indi-
vidual patient.
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Blocking experiments using neutralizing Abs confirmed that these
HMB-PP–dependent responses were mediated via BTN3 (Fig. 4C).
Strikingly, peritoneal Vg9/Vd2 T cells also responded to S. aureus
despite this organism’s lack of HMB-PP, possibly via superantigens
(20). Peritoneal MAIT cells were activated by the vit.B2+ bacteria
E. coli, K. pneumoniae, C. striatum, and S. aureus but not by the
vit.B22 species L. monocytogenes, E. faecalis, and S. pneumoniae;
responses to the vit.B2+ organism P. aeruginosa did not reach sta-
tistical significance (Fig. 4B).
Although Vg9/Vd2 T cells and MAIT cells constitute only minor
proportions of the peritoneal T cell pool, these cells represented
major producers of proinflammatory cytokines in response to bacterial
extracts (Fig. 5A). Using E. coli as example of an organism pro-
ducing both HMB-PP and vitamin B2, responding peritoneal Vg9/
Vd2 T cells and MAIT cells together made up a large fraction of
TNF-a+ T cells (median 31.7%) and IFN-g+ T cells (median 39.2%)
despite considerable variability across PD patients (Fig. 5B). In
contrast, both cell types constituted far lower proportions among
TNF-a2 and IFN-g2 T cells in E. coli–stimulated peritoneal
leukocytes. Similar results were obtained using HMB-PP+vit.B2+
C. striatum extracts (data not shown). Analyses of supernatants from
peritoneal leukocytes exposed to different bacteria demonstrated that
only organisms producing HMB-PP and/or vitamin B2 (S. aureus and
C. striatum) but not HMB-PP2vit.B22 E. faecalis induced secretion
of IFN-g and the IFN-g–inducible chemokine CXCL10 (Fig. 5C). As
control, levels of CXCL8 were comparable in response to all three
bacterial species, demonstrating an equal potential to stimulate
peritoneal leukocytes other than Vg9/Vd2 T cells and MAIT cells
(data not shown). Secretion of TNF-a was not assessed in these
experiments as any unconventional T cell–derived TNF-a would have
been masked by peritoneal macrophages and neutrophils sensing di-
verse pathogen-associated molecular patterns. The contribution of
Vg9/Vd2 T cells and MAIT cells to the overall secretion of IFN-g by
peritoneal leukocytes in response to HMB-PP+vit.B2+ organisms was
confirmed by anti-BTN3 and anti-MR1 blocking Abs (Fig. 5D).
Taken together, these findings show that peritoneal unconventional
T cells are major producers of IFN-g and TNF-a in response to a
wide range of microbial pathogens and that inhibition of ligand rec-
ognition through BTN3 and MR1 abrogates this cytokine production.
Cross-talk with local tissue amplifies the proinflammatory
response to bacterial pathogens
Local activation of unconventional T cells in acute infection is
likely to occur in close proximity to the peritoneal membrane, thus
exposing the mesothelial cell layer that lines the peritoneal cavity to
T cell–derived mediators. Using supernatants from activated un-
conventional T cells, our experiments demonstrate that Vg9/Vd2
T cells and MAIT cells induced secretion of CCL2, CXCL8,
CXCL10, and IL-6 by omentum-derived primary mesothelial cells
(Fig. 6A) and peritoneal fibroblasts (Fig. 6B). This activation of
peritoneal tissue cells was dose dependent (data not shown).
Neutralization of TNF-a and/or IFN-g in the conditioned media
prior to addition to peritoneal tissue cells attenuated these responses
considerably, with the CXCL8 and IL-6 secretion being particularly
sensitive to inhibition of TNF-a, whereas the CXCL10 secretion
was mainly driven by IFN-g (Fig. 6). These findings were in
FIGURE 4. Peritoneal unconventional T cell re-
sponses to microbial metabolites. (A) Activation of
peritoneal Vg9+ gd T cells and Va7.2+CD161+ MAIT
cells from stable PD patients upon overnight
stimulation with HMB-PP (n = 4 individual patients) or
DMRL (n = 3), as analyzed by flow cytometry and
expressed as proportion of gd or MAIT cells coex-
pressing CD69 and TNF-a (means 6 SEM). (B) Ac-
tivation of peritoneal Vg9+ gd T cells and Va7.2+
CD161+ MAIT cells upon overnight stimulation in the
presence of extracts from different clinical isolates that
produce (filled symbols) or do not produce (empty
symbols) the corresponding ligands (median 6 inter-
quartile range): E. coli (HMB-PP+vit.B2+), K. pneu-
moniae (HMB-PP+vit.B2+), P. aeruginosa (HMB-PP+vit.B2+),
C. striatum (HMB-PP+vit.B2+), L. monocytogenes
(HMB-PP+ vit.B22), S. aureus (HMB-PP2vit.B2+),
E. faecalis (HMB-PP2vit.B22), and S. pneumoniae
(HMB-PP2vit.B22). Data were analyzed using Krus-
kal–Wallis tests combined with Dunn’s multiple com-
parisons tests. Each data point represents an individual
patient. (C) Activation of total peritoneal leukocytes by
extracts of the indicated bacteria, in the absence or
presence of anti-BTN3 blocking Abs, shown as coex-
pression of CD69 and TNF-a (left) or IFN-g (right) by
Vg9+ T cells after overnight stimulation. Data were
analyzed using Wilcoxon matched–pairs signed rank
tests. Each data point represents an individual patient;
asterisks depict significant differences of anti-BTN3–
treated samples compared with untreated controls.
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accordance with control experiments showing that rTNF-a was a
potent inducer of CCL2, CXCL8, and IL-6 expression by meso-
thelial cells and fibroblasts (data not shown). rIFN-g on its own was
mainly effective at inducing CCL2 and, to a lesser extent, IL-6
expression by mesothelial cells and fibroblasts while having no
effect on CXCL8. These findings identify unconventional T cell–
derived TNF-a and IFN-g as major stimulators of peritoneal tissue
cells, which is likely to enhance local inflammation and contribute
to further recruitment of monocytes, neutrophils and lymphocytes
to the site of infection.
Activation of peritoneal tissue cells by effluent from PD
patients with acute peritonitis
We next sought to address the physiological relevance of the
findings above in more detail. Our previous work already dem-
onstrated that peritoneal effluent of patients presenting with acute
peritonitis can contain considerable levels of TNF-a and IFN-g
(13–15). We therefore tested whether cytokines released into the
dialysis fluid during acute infection had similar bioactivity to
unconventional T cell–conditioned media and the recombinant
proteins themselves. In this study, the effluent from three patients
with peritonitis induced CCL2 and CXCL8 secretion by meso-
thelial cells while effluent from stable patients showed only back-
ground activity (Fig. 7A). This chemokine production was in part
blocked by combined pretreatment of the infected effluent with
sTNFR and anti–IFN-g (Fig. 7B). These experiments demonstrate
that TNF-a and IFN-g are produced locally in response to bacterial
pathogens at concentrations that are sufficiently high to affect the
cells lining the peritoneal cavity, and that targeting cytokine pro-
duction by unconventional T cells may diminish local inflammation.
Clinical outcome from peritonitis depends on the capacity
of the causative pathogen to produce unconventional
T cell ligands
Acute inflammatory events make a major contribution to tissue
fibrosis. In particular, peritonitis has a direct effect on peritoneal
membrane morphology and function (21, 22) and is hence a major
reason for technique failure in PD patients. Yet, little is known
about the role of unconventional T cells in these processes. Given
the contribution of Vg9/Vd2 T cells and MAIT cells to the local
FIGURE 5. Ex vivo responsiveness of peritoneal leukocytes to pathogenic bacteria. Peritoneal cells were obtained from the effluent of stable patients and
exposed overnight to extracts prepared from the indicated bacterial species. (A) Representative example of an intracellular staining of TNF-a in peritoneal
leukocytes cultured in the absence (medium; top panel) or presence of E. coli extract (middle panel), as analyzed by flow cytometry within the CD3+ gate.
Bottom panel, distribution of Va7.2+ and Vg9+ cells within all CD3+TNF-a+ peritoneal cells after stimulation with E. coli extract. (B) Proportion of Va7.2+
(black) and Vg9+ cells (shaded) T cells among peritoneal T cells producing or not TNF-a and IFN-g in response to E. coli, as analyzed by flow cytometry in
nine stable individuals. (C) Overnight secretion of IFN-g, CXCL10, and CXCL8 by peritoneal cells in response to bacteria that produce (S. aureus,
C. striatum; filled circles) or do not produce (E. faecalis; empty circles) ligands for Vg9/Vd2 T cells and/or MAIT cells, as analyzed by ELISA (median 6
interquartile range). Data were analyzed using Kruskal–Wallis tests combined with Dunn’s multiple comparisons tests. Each data point represents an
individual patient; asterisks indicate significant differences compared with medium controls (triangles). (D) Specific inhibition of IFN-g secretion by
peritoneal leukocytes in response to bacterial extracts, in the absence or presence of anti-BTN3 and anti-MR1 blocking Abs, alone or in combination. Data
shown are means 6 SEM from independent experiments with three omental donors. ND, not done.
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immune response to HMB-PP+ and vit.B2+ bacteria, respectively,
we investigated the short- and midterm impact of infections by such
organisms on the clinical outcome in 5071 PD patients presenting
with first-time peritonitis recorded in the Australia and New Zea-
land Dialysis and Transplant (ANZDATA) Registry (Table I). In
accordance with our earlier findings in a much smaller subgroup of
the same cohort (14), infections by HMB-PP+ bacteria were asso-
ciated with poorer outcomes as determined by higher rates of
catheter removal, permanent transfer to HD, and overall technique
failure, compared with HMB-PP2 infections (Fig. 8, Table II). This
was true for episodes of peritonitis caused by both Gram+ and
Gram2 species, thereby identifying the utilization of the non-
mevalonate pathway of isoprenoid biosynthesis by the causative
organism as useful predictive marker and implying that Vg9/Vd2
T cell–driven responses may contribute to overall clinical outcome.
Within the HMB-PP+ group, Gram2 organisms caused even more
severe complications than Gram+ species, including significant
mortality within the first mo after the onset of acute peritonitis.
Because all HMB-PP+ bacteria in the ANZDATA cohort were
also positive for vitamin B2 (and did not include L. monocytogenes
as the only relevant HMB-PP+vit.B22 pathogen in PD patients),
outcome predictions based on the presence of the vitamin B2
pathway followed closely those seen for HMB-PP+ organisms
(Table II). However, differential analysis of HMB-PP2 infections
allowed us to determine the clinical impact of vit.B2+ species in
that patient subgroup. In this study, vit.B2+ infections showed a trend
toward higher rates of catheter removal, compared with vit.B22
infections, which was also reflected in total technique failure rates
(Fig. 8). However, no such differences between vit.B2+ and vit.B22
infections were seen with regard to transfer to HD or mortality. This
relatively benign course of HMB-PP2vit.B2+ peritonitis may have
been due to the high prevalence of infections caused by the com-
paratively avirulent skin commensal Staphylococcus epidermidis and
related coagulase-negative species (67.6% of all infections in this
group). As expected (23, 24), S. aureus infections were associated
with a considerably greater risk of technique failure and catheter
removal than coagulase-negative staphylococcal infections (data not
shown). These findings indicate that although the presence of the
vitamin B2 pathway alone may not be sufficiently predictive of
clinical outcome in that patient group, MAIT cells are nevertheless
likely to make a contribution to the overall inflammatory response
during acute peritonitis caused by vit.B2+ organisms.
Unconventional T cell–driven epithelial–mesenchymal
transition of peritoneal mesothelial cells
Finally, we investigated the functional impact of activated un-
conventional T cells on the surrounding tissue. Inflammatory
mediators including TNF-a have previously been associated with
the induction of an epithelial–mesenchymal transition (EMT)–like
process in mesothelial cells (25), and IFN-g has been identified as
FIGURE 6. Activation of perito-
neal tissue cells by gd T cell– and
MAIT cell–derived cytokines. Growth-
arrested peritoneal mesothelial cells
(A) or peritoneal fibroblasts (B) from
human omentum were exposed to
supernatants derived from activated
Vg9/Vd2 T cells and MAIT cells at a
dilution of 1:4, in the absence or
presence of 10 mg/ml sTNFR and
10 mg/ml anti–IFN-g, alone or to-
gether. Data shown are levels of
CCL2, CXCL8, CXCL10, and IL-6
secreted into the culture medium
over 24 h by ELISA (means 6 SEM
from independent experiments with
four to seven omental donors). Data
were analyzed using Friedman tests
combined with Dunn’s multiple com-
parisons tests. Asterisks indicate sig-
nificant differences compared with
medium controls.
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major driver of tissue fibrosis in the peritoneal cavity (22). In this
study, primary omentum-derived mesothelial cells exposed to
supernatants from activated Vg9/Vd2 T cells (data not shown) and
MAIT cells (Fig. 9A) underwent striking changes from an
epithelial-like appearance to a spindled fibroblastic shape within
24 h. Such pronounced morphological changes were greatly di-
minished when neutralizing TNF-a and/or IFN-g in the uncon-
ventional T cell–conditioned media prior to addition to mesothelial
cells (Fig. 9A). As controls, similar effects were observed when
mesothelial cells were cultured in the presence of TNF-a or IFN-g,
particularly when both cytokines were combined (Fig. 9B). In
agreement with these morphological changes, the expression of
epithelial cell–associated markers such as E-cadherin and occludin
by mesothelial cells was downregulated upon exposure to MAIT
cell–conditioned media, whereas the mesenchymal marker fibro-
nectin was upregulated, as determined by RT-quantitative PCR
(Fig. 9C). A similar upregulation of fibronectin expression was seen
with Vg9/Vd2 T cell–conditioned medium, whereas effects on
E-cadherin and occludin were less pronounced, most likely be-
cause of the generally lower levels of TNF-a and IFN-g in the
preparations used for those experiments, compared with MAIT cell–
conditioned medium (data not shown). As viability control, ex-
pression of IL-6 was greatly enhanced by unconventional T cells at
the mRNA level (data not shown), in agreement with the protein
data. In addition to fibronectin, MAIT cell–stimulated mesothelial
cells also expressed elevated levels of the miR miR-21, which has
been linked to TGF-b induced EMT in mesothelial cells and to
membrane fibrosis in patients receiving PD (M. Lopez-Anton and D.
J. Fraser, unpublished observations). This miR-21 induction by
MAIT cells was decreased upon neutralization of TNF-a and IFN-g
(Fig. 9D). Further epithelial (zona occludens-1; claudin) and mes-
enchymal markers (Snail, collagen-1, and a-smooth muscle actin)
were not significantly affected by unconventional T cell–secreted
factors (Fig. 9C, data not shown), indicating incomplete initiation
of the EMT process under these conditions. Notably, although
mesothelial cells treated with a combination of TNF-a and IFN-g
downregulated the expression of all epithelial markers tested (data
not shown), only Vg9/Vd2 T cells and MAIT cells triggered a
parallel upregulation of the mesenchymal marker fibronectin.
These data imply that unconventional T cells may produce as yet
unidentified mediators, in addition to TNF-a and IFN-g, that may
affect mesothelial cells and reprogram their morphology and
phenotype. Taken together, these findings indicate that microbe-
responsive unconventional T cells have the capacity to trigger
local tissue remodeling with potential consequences for peritoneal
membrane integrity and long-term clinical outcome.
Discussion
By combining cross-sectional and longitudinal sampling in PD
patients together with a functional characterization of peritoneal
immune and tissue cells ex vivo and an epidemiological analysis of
organism-dependent outcomes, we show that Vg9/Vd2 T cells and
MAIT cells specifically accumulate locally during infections with
bacteria producing HMB-PP and vitamin B2 derivatives, respec-
tively, and that utilization of the HMB-PP and vitamin B2 path-
ways by the causative organism represents an effective predictive
marker for technique failure. To our knowledge, our data thus
provide the first conclusive evidence in humans for a ligand-
specific role of Vg9/Vd2 T cells and MAIT cells at the site of
infection. Because of the limited access to relevant patient sam-
ples, such a physiological role has so far only been hinted at in
complex experimental animal models (26–28). Our data also show
that such unconventional human T cells are major producers of
IFN-g and TNF-a in response to microbial pathogens, thereby
affecting the cells lining the peritoneal cavity and amplifying local
inflammation. These findings are likely to be applicable to other
acute infections where local activation of unconventional T cells
contributes to the antimicrobial inflammatory response.
The present study demonstrates that PD patients offer excep-
tional opportunities for immunological studies into acute disease.
First, peritoneal effluent can be sampled repeatedly and noninvasively,
FIGURE 7. Activation of peritoneal tissue cells by effluent from PD
patients with acute peritonitis. (A) Growth-arrested peritoneal mesothelial
cells from human omentum (n = 2–4) were exposed to peritoneal effluent
obtained from three stable PD patients in the absence of any inflammation
(#1–3) and from three patients presenting with acute peritonitis (#4:
Enterobacter sp., #5: E. coli, and #6: Acinetobacter sp.). Data shown are
levels of CCL2 and CXCL8 secreted into the culture medium over 24 h by
ELISA (median6 interquartile range). Data were analyzed using Kruskal–
Wallis tests combined with Dunn’s multiple comparisons tests. Asterisks
indicate significant differences compared with medium controls (Ctrl). (B)
Mesothelial cells were exposed to peritoneal effluent from patients pre-
senting with peritonitis, in the absence or presence of 10 mg/ml sTNFR and
10 mg/ml anti–IFN-g. Data shown are expressed as percent inhibition of
CCL2 and CXCL8 secretion over 24 h, compared with untreated controls.
Data were analyzed using Wilcoxon matched–pairs signed rank tests. Each
data point represents an independent experiment.
Table I. Characteristics of all PD patients analyzed in the current study
Cardiff ANZDATA
No. of stable patients 45 n/a
Age (mean 6 SD) 69.1 6 13.5 n/a
Women (%) 18.6 n/a
d on PD (mean 6 SD) 624 6 546 n/a
No. of patients presenting
with acute peritonitis
101 5,071
Age (mean 6 SD) 66.0 6 13.3 60.1 6 16.9
Women (%) 32.6 43.9
d on PD (mean 6 SD) 936 6 856 1010 6 791
No of culture samples
obtained (%)
0.0 0.4
Culture negative episodes (%) 22.8 16.6
Fungi (%) 1.0 2.3
Polymicrobial infections (%) 4.0 6.8
HMB-PP+vit.B2+ species
among single bacteria (%)
34.2 35.3
HMB-PP2vit.B2+ species
among single bacteria (%)
42.5 50.2
HMB-PP2vit.B22 species
among single bacteria (%)
23.3 14.5
n/a, not applicable.
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thus providing continuous access to the site of infection on the
first d of microbial infection, before antibiotic therapy commences,
to study the development and resolution of acute responses. Second,
stable PD patients without overt inflammation can serve as age- and
gender-matched noninfected controls in cross-sectional studies.
Third, peritonitis remains a relatively frequent complication of PD
therapy, with typical incidences in the U.K. of one episode per 15–30
patient mo (29). Thorough immunological profiling of a stable PD
cohort therefore allows to establish preinfection baseline parameters
in individuals prone to develop peritonitis later on. Fourth, PD-
related peritonitis can be caused by Gram-positive and Gram-
negative bacteria as well as fungi, thereby allowing to study the
local immune response to a wide spectrum of pathogens under
closely related conditions. Because acute infection and associated
inflammation remain a major cause of treatment failure and even
death in PD patients (30), our findings not only improve our insight
into the complex local cell interactions in early infection but also
provide relevant clues to the mechanisms that underpin the clinical
severity of infectious episodes and are readily translatable to im-
prove patient management and outcomes.
Many unconventional T cell populations are rare in humans, with
NKT cells typically representing 0.01–0.5% of T cells in blood and
frequencies of germline-encoded mycolyl–reactive T cells being
even lower (31, 32). Given the rare nature of these populations and
the low prevalence of organisms that produce the corresponding
ligands in PD patients, we focused on Vg9/Vd2 T cells and
MAIT cells, the two most abundant unconventional T cell pop-
ulations in the peritoneal cavity. Our data provide in vitro and
in vivo evidence for the specificity of peritoneal Vg9/Vd2 T cells
and MAIT cells for the corresponding ligands, HMB-PP (33) and
vitamin B2 derivatives (16, 34). In particular, our research suggests
that Vg9/Vd2 T cells and MAIT cells discriminate locally between
different organisms and accumulate rapidly at the site of infection,
where they engage local monocytes and neutrophils as well as
tissue cells, and orchestrate early inflammatory events (10, 13, 14).
Although others have suggested that circulating MAIT cells de-
crease in certain clinical scenarios sufficiently to reach statistical
significance (35), to our knowledge, our data indicate for the first
time that local recruitment of MAIT cells indeed takes place in
acute infection. Unconventional T cell–driven responses are likely
to contribute to the transition from local innate immunity to Ag-
specific adaptive immunity (11) and have potential to be exploited
for improved patient management through novel diagnostics, ther-
apeutics and vaccines. As such, we show in this study that local
Vg9/Vd2 T cells and MAIT cells represent dominant sources of
IFN-g and TNF-a in response to diverse bacteria. As these cyto-
kines control leukocyte recruitment to the site of infection but also
possess profibrotic functions, unconventional T cells represent key
regulators of acute immune responses as well as collateral tissue
damage, ultimately affecting outcomes.
The present study identified unconventional T cell–derived
TNF-a and IFN-g as potent stimulators of primary mesothelial
cells and peritoneal fibroblasts, the two major types of tissue cells
constituting the peritoneal membrane. Through induction of IL-6
as well as chemokines such as CCL2, CXCL8, and CXCL10,
Vg9/Vd2 T cells and MAIT cells are likely to enhance local in-
flammation and contribute to further recruitment of monocytes,
neutrophils, and lymphocytes to the site of infection. This inter-
action with local tissue cells complements our earlier findings on
a potent cross-talk of Vg9/Vd2 T cells and MAIT cells with
monocytes and neutrophils triggering chemokine production and
leading to monocyte and neutrophil survival and acquisition of
APC features (10, 11, 13, 14). Taken together, these findings in-
dicate that Vg9/Vd2 T cells and MAIT cells play a crucial role in
driving local inflammatory events by engaging both immune and
nonimmune cells at the site of infection by organisms producing the
corresponding ligands. The timely detection of Vg9/Vd2 T cell and
MAIT cell responses in PD patients presenting with acute peritonitis
may therefore allow an “immune fingerprint”–based point-of-care
definition of the causative pathogen, which would improve early
patient management by targeting treatments more efficiently than
current empirical approaches, reducing unnecessary exposure to
broad-spectrum antibiotics, and identifying individuals at increased
risk of subsequent complications who may require prolonged
hospitalization (15, 36).
The orchestration of early antimicrobial responses by uncon-
ventional T cells is likely to contribute to pathogen clearance and
wound healing and thus be beneficial to the host in different in-
fectious scenarios. However, the situation is different in individuals
receiving PD who are highly susceptible to inflammation-related
tissue damage with immediate consequences for their treatment
FIGURE 8. Association of first-time peritonitis caused by HMB-PP+ and
vit.B2+ bacteria with poor clinical outcome. Cumulative rates of technique
failure (top left), mortality (top right), catheter removal (middle), and transfer
to permanent HD (bottom) of patients from the ANZDATA registry with
first-time peritonitis, grouped into infections with Gram+HMB-PP2vit.B22
(green), Gram+HMB-PP2vit.B2+ (gray), Gram+HMB-PP+vit.B2+ (blue), or
Gram2HMB-PP+ vit.B2+ bacteria (red); episodes caused by Gram2HMB-PP2
(e.g., Legionella spp.) or Gram+HMB-PP+vit.B22 species (e.g., L. mono-
cytogenes) were not recorded and/or were too rare for this comparison.
Numbers indicate the number of cases of acute peritonitis caused by the listed
organisms. Comparisons were made using log-rank tests.
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(37–39). In particular, IL-6 has been linked to tissue fibrosis via
induction of Th1 cell responses as a consequence of peritoneal
inflammation (22). Unconventional T cells are therefore likely to
contribute to scarring in the peritoneal cavity, both directly via the
local release of IFN-g and indirectly via induction of IL-6 pro-
duction by mesothelial cells and fibroblasts. Our present study
identified striking morphological and phenotypical changes of
mesothelial cells in response to Vg9/Vd2 T cells and MAIT cell
secreted cytokines, changes that are linked to infection-driven
peritoneal fibrosis and technique failure. Such local tissue
remodeling by downregulating epithelial features and inducing
expression of mesenchymal markers will ultimately affect the
integrity of the peritoneal membrane and affect long-term clinical
outcomes. Together, these complex interactions may, at least in
part, explain why organisms that are capable of activating local
unconventional T cells are frequently associated with higher rates
of technique failure in PD patients. Besides predicting important
clinical outcomes, unconventional T cell–driven responses to ligands
shared by many microbial pathogens therefore also represent
potential targets to suppress overshooting inflammation and limit
damage on the peritoneal membrane, with the possibility to deliver
treatments locally via the peritoneal catheter. Novel interventions
will benefit greatly from the recent elucidation of the BTN3 and
MR1 presentation pathways, and the availability of reagents block-
ing the TCR-mediated recognition of microbial ligands (40, 41),
antibiotics shutting off the nonmevalonate and riboflavin biosyn-
thesis (42–45), and biologics interfering with key effector cytokines.
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FIGURE 9. Unconventional T
cell–induced reprogramming of peri-
toneal mesothelial cells. Growth-
arrested peritoneal mesothelial cells
from human omentum were cultured
in medium alone or exposed to su-
pernatants derived from activated
MAIT cells, in the absence or pres-
ence of 10mg/ml sTNFR and 10mg/ml
anti–IFN-g (A), or stimulated with
5 ng/ml TNF-a and IFN-g, alone or
in combination (B). Images were
captured after 24 h in culture with a
light microscope at original magni-
fication 320 and are representative
of three to four individual donors.
(C) Expression of epithelial (E-cad-
herin, occludin, zona occludens-1
[ZO-1], and claudin-1) and mesen-
chymal markers (fibronectin and
Snail) by mesothelial cells after 24 h
exposure to MAIT cell supernatants,
as determined by quantitative PCR
as relative expression compared with
1000 copies of GAPDH as house-
keeping gene. (D) Expression of
miR-21 by mesothelial cells after
24 h exposure to MAIT cell super-
natants in the absence or presence of
10 mg/ml sTNFR and 10 mg/ml
anti–IFN-g, as determined by quan-
titative PCR as relative expression
compared with miR-191 as reference
miR. Data were analyzed using
Wilcoxon matched–pairs signed rank
tests or paired t tests. Each data point
represents an individual patient.
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